SPP1 and hepatocellular carcinoma: Employing GEPIA2 (66), we conducted Kaplan-Meier survival analysis and univariate Cox survival analysis, both of which provided compelling evidence that elevated levels of SPP1 are associated with poor patient outcomes (Figure 7A), confirming the unfavorable role of SPP1 expression in HCC.